Please use this identifier to cite or link to this item:
https://hdl.handle.net/10356/160848| Title: | Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents | Authors: | Ruffles, Tom Jones, Christina J. Palmer, Colin Turner, Steve Grigg, Jonathan Tavendale, Roger Hogarth, Fiona Rauchhaus, Petra Pilvinyte, Kristina Hannah, Romanie Smith, Helen Elizabeth Littleford, Roberta Lipworth, Brian Mukhopadhyay, Somnath |
Keywords: | Science::Medicine | Issue Date: | 2021 | Source: | Ruffles, T., Jones, C. J., Palmer, C., Turner, S., Grigg, J., Tavendale, R., Hogarth, F., Rauchhaus, P., Pilvinyte, K., Hannah, R., Smith, H. E., Littleford, R., Lipworth, B. & Mukhopadhyay, S. (2021). Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents. European Respiratory Journal, 58(2), 2004107-. https://dx.doi.org/10.1183/13993003.04107-2020 | Journal: | European Respiratory Journal | Abstract: | The A allele of rs1042713 (Arg16 amino acid) in the β2-adrenoreceptor is associated with poor response to long-acting β2-agonist (LABA) in young people with asthma. Our aim was to assess whether the prescribing of second-line controller with LABA or a leukotriene receptor antagonist according to Arg16Gly genotype would result in improvements in Pediatric Asthma-Related Quality of Life Questionnaire (PAQLQ). | URI: | https://hdl.handle.net/10356/160848 | ISSN: | 0903-1936 | DOI: | 10.1183/13993003.04107-2020 | Schools: | Lee Kong Chian School of Medicine (LKCMedicine) | Rights: | © 2021 The authors. All rights reserved. | Fulltext Permission: | none | Fulltext Availability: | No Fulltext |
| Appears in Collections: | LKCMedicine Journal Articles |
SCOPUSTM
Citations
20
8
Updated on Sep 30, 2023
Web of ScienceTM
Citations
20
6
Updated on Sep 28, 2023
Page view(s)
35
Updated on Oct 3, 2023
Google ScholarTM
Check
Altmetric
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.